Pentagon orders mandatory testosterone tests for male troops 30 and older

Pentagon Announces Mandatory Testosterone Screening for Service Members 30 and Older

Washington, D.C. – In a move aimed at bolstering military readiness and long‑term health, the Department of Defense issued new clinical guidelines on Wednesday that will require active‑duty and reserve soldiers, sailors, airmen, marines, and Coast Guard personnel who are 30 years old or older to undergo routine testosterone deficiency screening. The policy goes into effect immediately.

What the Guidelines Cover

Under the new rules, men in the 30‑to‑39 age bracket will receive a blood test for testosterone levels as part of their standard medical evaluation. Men younger than 30 will only be tested if a clinician suspects a problem or if the individual requests testing. If a test shows low testosterone, a follow‑up assessment will determine whether hormone replacement therapy is appropriate, and service members will be offered this treatment on a voluntary basis.

Women are not subject to routine testosterone testing. However, they will be screened for symptoms such as fatigue and irregular menstrual cycles that may indicate hormonal imbalances or conditions related to low energy availability—a concern for athletes and active individuals. The guidelines also clarify when it may be acceptable to prescribe off‑label testosterone to women, such as postmenopausal women experiencing markedly reduced libido.

The policy makes it clear that non‑prescribed testosterone use for performance enhancement remains forbidden in the armed forces.

Rationale Behind the Move

Defense Secretary Pete Hegseth, who first announced the program in July, emphasized that the goal is to “ensure you have the right testosterone levels to operate at your absolute best.” He added, “Taking care of your long‑term health means ensuring you remain strong, resilient and capable — not just for your next deployment, but for the rest of your life, so you can thrive long after you take off the uniform.”

The Pentagon says the standardized screening and treatment pathways are designed to identify and manage hormonal and energy‑availability issues that could compromise readiness.

Expert Reactions

Not all medical professionals agree that universal testing is a net benefit. Endocrinologists and other specialists have expressed concern that widespread screening could lead to unnecessary or even harmful treatments, citing a lack of robust evidence that routine testosterone testing improves operational readiness or health outcomes. Some experts point out that testosterone naturally declines between ages 30 and 40, and that many men experience low levels without significant symptoms or functional impairment.

The Food and Drug Administration plans to convene a meeting with experts later this month to discuss the medical use of testosterone, including its role in treatment and the potential risks associated with off‑label prescribing.

Next Steps

The Department of Defense will monitor the implementation of the guidelines and gather data on how testosterone screening affects health and readiness metrics. Service members will be notified through standard medical channels about the new testing requirements, and clinical staff will receive training on the updated protocols.

While the policy has sparked debate among medical professionals, its proponents maintain that early detection of hormonal deficiencies can prevent future health complications and enhance the overall resilience of the U.S. armed forces. Whether the initiative will achieve its intended goals remains to be seen, as the Department of Defense and the medical community prepare to evaluate the program’s impact in the coming months.